Antibodies

10 Dec 2007 Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma
10 Dec 2007 Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
10 Dec 2007 Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10 Dec 2007 Biolex Researchers Present Results of Anti-CD20 Antibody With Optimized Glycosylation at ASH Conference
09 Dec 2007 ImmunoGen, Inc. Announces Encouraging Clinical Findings Reported at ASH Annual Meeting for TAP Compound AVE9633
08 Dec 2007 ImmunoGen, Inc. Announces Encouraging Clinical Findings Reported at ASH Annual Meeting with Targeted Anticancer Compounds IMGN901 (HuN901-DM1) and AVE1642
07 Dec 2007 Genmab's HuMax-CD38 Enters Phase I/II Clinical Trial For Multiple Myeloma
07 Dec 2007 Seattle Genetics Initiates SGN-40 Phase IIb Clinical Trial in Combination with Rituxan and Chemotherapy for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
06 Dec 2007 Raven biotechnologies, Inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
05 Dec 2007 Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
05 Dec 2007 BioInvent Designates Drug Candidate, BI-505, for the Treatment of Cancer
05 Dec 2007 Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product
05 Dec 2007 Genentech Provides Update From Avastin FDA Advisory Meeting
05 Dec 2007 Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
04 Dec 2007 Centocor and Janssen-Cilag Submit Appplications Requesting Approval of Ustekinumab in the U.S. and Europe For Treatment of Moderate to Severe Plaque Psoriasis
04 Dec 2007 Arana Announces Phase II Trials For Lead Compound ART621
04 Dec 2007 Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement
04 Dec 2007 Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
04 Dec 2007 Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
03 Dec 2007 "Actemra(R)," a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, Filed for Rheumatoid Arthritis in Europe
02 Dec 2007 Novartis further strengthens biologics capabilities in expansion of MorphoSys collaboration
29 Nov 2007 New Data Highlight That Treatment With Erbitux Allows More Resections of Preteated Patients With Metastatic Colorectal Cancer
29 Nov 2007 Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies
28 Nov 2007 MediGene and Celltrion Announce Co-development of Anti-L1 Monoclonal Antibody Therapeutic for Treating Cancer
26 Nov 2007 MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top